A detailed history of State Street Corp transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, State Street Corp holds 3,740,356 shares of AVXL stock, worth $21.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,740,356
Previous 7,299,007 48.76%
Holding current value
$21.4 Million
Previous $37.2 Million 57.51%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.39 - $5.02 $12.1 Million - $17.9 Million
-3,558,651 Reduced 48.76%
3,740,356 $15.8 Million
Q1 2024

May 15, 2024

BUY
$4.55 - $6.75 $16.6 Million - $24.7 Million
3,656,305 Added 100.37%
7,299,007 $37.2 Million
Q4 2023

Feb 14, 2024

BUY
$5.04 - $9.95 $86,955 - $171,667
17,253 Added 0.48%
3,642,702 $33.9 Million
Q3 2023

Nov 14, 2023

SELL
$6.55 - $9.37 $5.13 Million - $7.34 Million
-783,488 Reduced 17.77%
3,625,449 $23.7 Million
Q2 2023

Aug 14, 2023

SELL
$7.66 - $9.5 $9.72 Million - $12.1 Million
-1,268,439 Reduced 22.34%
4,408,937 $35.8 Million
Q1 2023

May 15, 2023

SELL
$8.32 - $11.75 $1.13 Million - $1.59 Million
-135,229 Reduced 2.33%
5,677,376 $48.7 Million
Q4 2022

Feb 14, 2023

BUY
$7.65 - $14.43 $11.1 Million - $20.9 Million
1,451,167 Added 33.27%
5,812,605 $53.8 Million
Q3 2022

Nov 15, 2022

SELL
$8.9 - $12.86 $1.14 Million - $1.64 Million
-127,807 Reduced 2.85%
4,361,438 $45 Million
Q2 2022

Aug 15, 2022

SELL
$7.31 - $12.84 $7.95 Million - $14 Million
-1,088,011 Reduced 19.51%
4,489,245 $44.9 Million
Q1 2022

May 16, 2022

BUY
$9.74 - $17.69 $17 Million - $30.8 Million
1,743,222 Added 45.47%
5,577,256 $68.7 Million
Q4 2021

Feb 14, 2022

SELL
$16.88 - $23.31 $5.59 Million - $7.72 Million
-331,386 Reduced 7.96%
3,834,034 $66.5 Million
Q3 2021

Nov 15, 2021

BUY
$16.82 - $25.75 $1.57 Million - $2.41 Million
93,447 Added 2.29%
4,165,420 $74.8 Million
Q2 2021

Aug 16, 2021

BUY
$10.16 - $28.86 $13.5 Million - $38.2 Million
1,324,794 Added 48.22%
4,071,973 $93.1 Million
Q1 2021

May 17, 2021

BUY
$5.17 - $16.13 $9.68 Million - $30.2 Million
1,872,614 Added 214.12%
2,747,179 $41.1 Million
Q4 2020

Feb 16, 2021

SELL
$4.01 - $7.58 $63,859 - $120,711
-15,925 Reduced 1.79%
874,565 $4.72 Million
Q3 2020

Nov 10, 2020

BUY
$3.8 - $5.0 $53,652 - $70,595
14,119 Added 1.61%
890,490 $4.05 Million
Q2 2020

Aug 14, 2020

BUY
$2.62 - $5.2 $140,416 - $278,688
53,594 Added 6.51%
876,371 $4.31 Million
Q1 2020

May 11, 2020

BUY
$2.38 - $5.81 $1.96 Million - $4.78 Million
822,777 New
822,777 $2.59 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $446M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.